Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

AIM ImmunoTech Inc. (AIM)

1.06   -0.01 (-0.93%) 02-24 16:00
Open: 1.12 Pre. Close: 1.07
High: 1.12 Low: 1.03
Volume: 2,064,114 Market Cap: 9M
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency disorders in the United States. The company's products include Alferon N Injection, an injectable formulation of natural alpha interferon to treat a category of genital warts, a sexually transmitted disease; and Ampligen for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of CFS, Hepatitis B, HIV, and cancer patients with renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, urothelial, prostate, and pancreatic cancer. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was founded in 1966 and is headquartered in Ocala, Florida.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.121 - 1.127 1.127 - 1.132
Low: 1.015 - 1.021 1.021 - 1.028
Close: 1.048 - 1.058 1.058 - 1.069

Technical analysis

as of: 2020-02-24 4:40:56 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 1.47     One year: 1.87
Support: Support1: 0.70    Support2: 0.58
Resistance: Resistance1: 1.26    Resistance2: 1.60
Pivot: 1.07
Moving Average: MA(5): 1.06     MA(20): 1.06
MA(100): 0.66     MA(250): 1.92
MACD: MACD(12,26): 0.07     Signal(9): 0.08
Stochastic oscillator: %K(14,3): 33.74     %D(3): 33.88
RSI: RSI(14): 53.78
52-week: High: 14.96  Low: 0.09  Change(%): -88.0
Average Vol(K): 3-Month: 273338  10-Days: 883666

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
AIM has closed above bottom band by 48.4%. Bollinger Bands are 6.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Loyalty Programs Market Procurement Intelligence Report | Evolving Opportunities with Aimia and Maritz Holdings in the Loyalty Programs Market | SpendEdge
LONDON--(BUSINESS WIRE)-- #MarketIntelligence--Read the 128-page research report with TOC and LOE on The Global Loyalty Programs Market Procurement Intelligence Report, Top Suppliers

2 high-paying dividend stocks on AIM: a risk or a reward?
AIM shares are notoriously risky. Are these dividend-payers worth considering? The post 2 high-paying dividend stocks on AIM: a risk or a reward? appeared first on The Motley Fool UK .

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE American
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 8.26
Shares Float (M) 7.33
% Held by Insiders 6.68
% Held by Institutions 10.83
Shares Short (K) 127
Shares Short P. Month (K)

Stock Financials

EPS -5.873
Book Value (p.s.) 2.140
PEG Ratio -0.02
Profit Margin
Operating Margin -3628.79
Return on Assets (ttm) -39.8
Return on Equity (ttm) -98.1
Qtrly Rev. Growth 60.5
Gross Profit (p.s.) -0.063
Sales Per Share
EBITDA (p.s.) -1.360
Qtrly Earnings Growth
Operating Cash Flow (M) -9.20
Levered Free Cash Flow (M) -6.08

Stock Valuations

P/E -0.18
P/E Growth Ratio -0.01
P/BV 0.50
P/S 5.57
P/CF -0.95

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2019-06-10
Last Split Ratio 0.023
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.